Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
MKNK1 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 33.90 | Evidence | |||||
MKNK1 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 31.10 | Evidence | |||||
MKNK1 | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 22.90 | Evidence | |||||
MKNK1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 20.50 | Evidence | |||||
MKNK1 | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 20.50 | Evidence | |||||
MKNK1 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 20.50 | Evidence | |||||
MKNK1 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 20.50 | Evidence | |||||
MKNK1 | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 20.50 | Evidence | |||||
MKNK1 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
MKNK1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 19.70 | Evidence | |||||
MKNK1 | IRS1 | IRS1: Insulin receptor substrate 1 | 19.70 | Evidence | |||||
MKNK1 | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 19.70 | Evidence | |||||
MKNK1 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 19.70 | Evidence | |||||
MKNK1 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 17.60 | Evidence | |||||
MKNK1 | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 17.60 | Evidence | |||||
MKNK1 | STAT3 | 17.60 | Evidence | ||||||
MKNK1 | LYN | LYN: Tyrosine-protein kinase Lyn | 17.60 | Evidence | |||||
MKNK1 | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 17.60 | Evidence | |||||
MKNK1 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 17.60 | Evidence | |||||
MKNK1 | STMN1 | STMN1, LAP18, OP18: Stathmin | 17.60 | Evidence | |||||
MKNK1 | SYK | SYK: Tyrosine-protein kinase SYK | 17.60 | Evidence | |||||
MKNK1 | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 17.60 | Evidence | |||||
MKNK1 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 13.40 | Evidence | |||||
MKNK1 | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 13.00 | Evidence | |||||
MKNK1 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 13.00 | Evidence | |||||
MKNK1 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 13.00 | Evidence | |||||
MKNK1 | JUN | JUN: Transcription factor AP-1 | 10.30 | Evidence | |||||
MKNK1 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 10.30 | Evidence | |||||
MKNK1 | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 9.96 | Evidence | |||||
MKNK1 | CASP9 | CASP9, MCH6: Caspase-9 precursor | 9.96 | Evidence | |||||
MKNK1 | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 9.96 | Evidence | |||||
MKNK1 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 9.96 | Evidence | |||||
MKNK1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 8.92 | Evidence | |||||
MKNK1 | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 8.92 | Evidence | |||||
MKNK1 | JUND | JUND: Transcription factor jun-D | 8.92 | Evidence | |||||
MKNK1 | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 8.92 | Evidence | |||||
MKNK1 | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 8.92 | Evidence | |||||
MKNK1 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 8.92 | Evidence | |||||
MKNK1 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 8.92 | Evidence | |||||
MKNK1 | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 8.92 | Evidence | |||||
MKNK1 | PTPRA | N/A | 7.14 | Evidence | |||||
MKNK1 | GJA1 | GJA1, GJAL: Gap junction alpha-1 protein | 7.14 | Evidence | |||||
MKNK1 | TH | TH, TYH: Tyrosine 3-monooxygenase | 6.39 | Evidence | |||||
MKNK1 | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 6.24 | Evidence | |||||
MKNK1 | RAB4A | N/A | 6.24 | Evidence | |||||
MKNK1 | AMPH | AMPH, AMPH1: Amphiphysin | 6.24 | Evidence | |||||
MKNK1 | CD44 | N/A | 5.87 | Evidence | |||||
MKNK1 | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 5.87 | Evidence | |||||
MKNK1 | EPOR | EPOR: Erythropoietin receptor precursor | 5.87 | Evidence | |||||
MKNK1 | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 5.59 | Evidence | |||||
MKNK1 | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 5.59 | Evidence | |||||
MKNK1 | PSMA4 | PSMA4, PSC9: Proteasome subunit alpha type-4 | 5.47 | Evidence | |||||
MKNK1 | PSMA6 | PSMA6, PROS27: Proteasome subunit alpha type-6 | 5.47 | Evidence | |||||
MKNK1 | PSMA7 | PSMA7: Proteasome subunit alpha type-7 | 5.47 | Evidence | |||||
MKNK1 | ATP1A1 | ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor | 5.26 | Evidence | |||||
MKNK1 | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 5.26 | Evidence | |||||
MKNK1 | KRT8 | KRT8, CYK8: Keratin, type II cytoskeletal 8 | 4.68 | Evidence | |||||
MKNK1 | C1QBP | C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot | 4.19 | Evidence | |||||
MKNK1 | BCL2 | BCL2: Apoptosis regulator Bcl-2 | 4.03 | Evidence | |||||
MKNK1 | PTPN7 | N/A | 3.88 | Evidence | |||||
MKNK1 | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 3.88 | Evidence | |||||
MKNK1 | OSBPL6 | OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 | 3.70 | Evidence | |||||
MKNK1 | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 3.70 | Evidence | |||||
MKNK1 | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 3.70 | Evidence | |||||
MKNK1 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 3.47 | Evidence | |||||
MKNK1 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 3.47 | Evidence | |||||
MKNK1 | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 3.47 | Evidence | |||||
MKNK1 | PABPC1 | PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 | 3.47 | Evidence | |||||
MKNK1 | WASPIP | N/A | 3.47 | Evidence | |||||
MKNK1 | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 3.47 | Evidence | |||||
MKNK1 | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 3.34 | Evidence | |||||
MKNK1 | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 3.34 | Evidence | |||||
MKNK1 | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 3.34 | Evidence | |||||
MKNK1 | TOP2B | N/A | 3.34 | Evidence | |||||
MKNK1 | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 3.34 | Evidence | |||||
MKNK1 | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 3.34 | Evidence | |||||
MKNK1 | DUSP4 | DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 | 3.31 | Evidence | |||||
MKNK1 | DUSP2 | DUSP2, PAC1: Dual specificity protein phosphatase 2 | 3.31 | Evidence | |||||
MKNK1 | SORBS3 | SORBS3, SCAM1: Vinexin | 2.99 | Evidence | |||||
MKNK1 | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 2.99 | Evidence | |||||
MKNK1 | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 2.99 | Evidence | |||||
MKNK1 | MAP2K3 | N/A | 2.99 | Evidence | |||||
MKNK1 | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 2.99 | Evidence | |||||
MKNK1 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 2.99 | Evidence | |||||
MKNK1 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 2.99 | Evidence | |||||
MKNK1 | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 2.99 | Evidence | |||||
MKNK1 | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 2.99 | Evidence | |||||
MKNK1 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 2.99 | Evidence | |||||
MKNK1 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 2.99 | Evidence | |||||
MKNK1 | TP53 | TP53, P53: Cellular tumor antigen p53 | 2.99 | Evidence | |||||
MKNK1 | PTPN11 | N/A | 2.99 | Evidence | |||||
MKNK1 | MAPT | N/A | 2.72 | Evidence |